trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kiliccioglu I et al. Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines. 2014 Genet. Mol. Res. pmid:24854658
Yang DH et al. Dynamic rearrangement of F-actin is required to maintain the antitumor effect of trichostatin A. 2014 PLoS ONE pmid:24846135
Kumafuji M et al. Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module. 2014 Genes Cells pmid:24840924
Zhang Y et al. Autophagy in pulmonary macrophages mediates lung inflammatory injury via NLRP3 inflammasome activation during mechanical ventilation. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:24838752
Bezecny P Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. 2014 Med. Oncol. pmid:24838514
Wang Y et al. Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. 2015 J. Mol. Neurosci. pmid:24829091
Skoge RH et al. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels. 2014 DNA Repair (Amst.) pmid:24814981
Meier BC and Wagner BK Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. 2014 Epigenomics pmid:24811789
Motevalli A et al. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. 2014 Breast Cancer Res. Treat. pmid:24807106
Guo W et al. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. 2014 Cancer pmid:24798237
Peiffer L et al. Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation. 2014 J. Cancer Res. Clin. Oncol. pmid:24793644
Palii CG et al. Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. 2014 Cell Stem Cell pmid:24792117
Soler E and Grosveld F Targeting epigenetics to speed up repair. 2014 Cell Stem Cell pmid:24792110
Guo J et al. Effect of 5-aza-2'-deoxycytidine combined with trichostatin A on RPMI-8226 cell proliferation, apoptosis and DLC-1 gene expression. 2014 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:24763005
Cheng X et al. Generation and characterization of gsuα:EGFP transgenic zebrafish for evaluating endocrine-disrupting effects. 2014 Toxicol. Appl. Pharmacol. pmid:24747804
Herr MJ et al. Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity. 2014 Biochem. Biophys. Res. Commun. pmid:24747564
Poplutz MK et al. Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. 2014 Immunobiology pmid:24746556
Rafehi H et al. Vascular histone deacetylation by pharmacological HDAC inhibition. 2014 Genome Res. pmid:24732587
Ma XH et al. Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats. 2015 Int. J. Neurosci. pmid:24730998
Hassan MK et al. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection. 2014 PLoS ONE pmid:24728004
Drela K et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. 2014 Cytotherapy pmid:24726658
Zhu XJ et al. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. 2014 Mol Med Rep pmid:24718752
Yan YE et al. Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. 2014 Toxicol. Appl. Pharmacol. pmid:24709674
Tu CY et al. Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. 2014 Biomed Res Int pmid:24707474
Zhang YW et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. 2014 Epigenetics pmid:24699858
Fetahu IS et al. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. 2014 Int. J. Cancer pmid:24691920
Boyer JG et al. Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. 2014 Hum. Mol. Genet. pmid:24691550
Deneberg S et al. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. 2014 Epigenetics pmid:24686393
Saccone V et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. 2014 Genes Dev. pmid:24682306
Yang J et al. PTEN methylation involved in benzene-induced hematotoxicity. 2014 Exp. Mol. Pathol. pmid:24680972
Cherry KE et al. Identification of Tf1 integration events in S. pombe under nonselective conditions. 2014 Gene pmid:24680781
Zuo X et al. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. 2014 Oncol. Rep. pmid:24676336
Wisnieski F et al. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. 2014 Tumour Biol. pmid:24668547
Sugimoto H et al. Production of somatic cell nuclear transfer embryos using in vitro-grown and in vitro-matured oocytes in rabbits. 2015 Zygote pmid:24666637
Varol N et al. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24). 2014 DNA Cell Biol. pmid:24665856
Aune SE et al. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. 2014 J. Mol. Cell. Cardiol. pmid:24632412
Yuan TF et al. The epigenetics changes in Parkinson's disease: a novel therapeutic target. 2014 CNS Neurosci Ther pmid:24629108
Sun S et al. Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells. 2014 PLoS ONE pmid:24626188
Kilinc V et al. Do iron chelators increase the antiproliferative effect of trichostatin A through a glucose-regulated protein 78 mediated mechanism? 2014 Tumour Biol. pmid:24622883
Kizuka Y et al. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. 2014 J. Biol. Chem. pmid:24619417
Guilluy C et al. Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus. 2014 Nat. Cell Biol. pmid:24609268
Chen HY et al. Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury. 2014 Pharmazie pmid:24601225
Johnson JL et al. The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure. 2014 J. Invest. Dermatol. pmid:24594668
Blank M et al. Basolateral amygdala activity is required for enhancement of memory consolidation produced by histone deacetylase inhibition in the hippocampus. 2014 Neurobiol Learn Mem pmid:24583371
Saayman S et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. 2014 Mol. Ther. pmid:24576854
McEachern LA and Murphy PR Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus. 2014 Mol. Endocrinol. pmid:24552587
Zou JY and Crews FT Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. 2014 PLoS ONE pmid:24551070
Chu Y et al. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers. 2014 Cell. Mol. Life Sci. pmid:24531693
Sakharkar AJ et al. Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. 2014 Int. J. Neuropsychopharmacol. pmid:24528596
Al-Rayyan N et al. 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. 2014 Cancer Lett. pmid:24513177